Concepedia

Michel Ségui

MS

7

Publications

560

Citations

7

H-Index

1994

Active since

Affiliations

Sanofi (France)(Current)

Michel Ségui is an author at Sanofi (France) specializing in inflammation, immunology, and allergy.

Top concepts

Publications per year

1994–2000

7

Publications

7

Cannabinoids enhance human B‐cell growth at low nanomolar concentrations

Jean‐Marie Derocq, Michel Ségui, J Marchand et al. · FEBS Letters · 1995 · 167 citations

Genomic and Functional Changes Induced by the Activation of the Peripheral Cannabinoid Receptor CB2 in the Promyelocytic Cells HL-60

Jean‐Marie Derocq, Omar Jbilo, Monsif Bouaboula et al. · Journal of Biological Chemistry · 2000 · 98 citations · Full text

The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor‐independent pathway in hematopoietic cell lines

Jean‐Marie Derocq, Monsif Bouaboula, J Marchand et al. · FEBS Letters · 1998 · 78 citations

, , +20

Interleukin‐13 stimulates interleukin‐6 production by human keratinocytes

Jean‐Marie Derocq, Michel Ségui, C. Poinot-Chaze et al. · FEBS Letters · 1994 · 63 citations

, , +16

Stimulation of peripheral cannabinoid receptor CB2 induces MCP‐1 and IL‐8 gene expression in human promyelocytic cell line HL60

Omar Jbilo, Jean‐Marie Derocq, Michel Ségui et al. · FEBS Letters · 1999 · 57 citations

Rows per page

1–5 of 7